Key Financial Data Of Group

KYORIN Pharmaceutical Co., Ltd. - Filing #7550544

Concept As at
2023-06-30
2023-04-01 to
2023-06-30
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2022-06-30
As at
2022-06-30
Key financial data of group
Business results of group
Net sales
27,854,000,000 JPY
113,270,000,000 JPY
24,619,000,000 JPY
Ordinary profit (loss)
913,000,000 JPY
5,827,000,000 JPY
779,000,000 JPY
Profit (loss) attributable to owners of parent
676,000,000 JPY
4,723,000,000 JPY
1,183,000,000 JPY
Comprehensive income
1,152,000,000 JPY
3,986,000,000 JPY
2,367,000,000 JPY
Net assets
124,753,000,000 JPY
125,461,000,000 JPY
125,014,000,000 JPY
Total assets
172,542,000,000 JPY
176,045,000,000 JPY
171,001,000,000 JPY
Basic earnings (loss) per share
11.81
82.44
20.65
Diluted earnings per share
Equity-to-asset ratio
0.723 xbrli:pure
0.713 xbrli:pure
0.731 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.